Drug intelligence / Profile preview

Bepanthenol Sensiderm

Development stage
Unknown
Lead developer
Bayer
Administration
Topical
01

Overview

Bepanthenol Sensiderm (also marketed as Bepanthen Sensiderm) is a cortisone-free topical medical device cream developed and marketed by Bayer. It is indicated for the rapid relief of itching and redness associated with various skin irritations, including atopic dermatitis, eczema, dry skin, and allergic skin reactions. The cream employs a proprietary lamellar lipid technology containing ceramide-like lipids that mimic and integrate into the damaged stratum corneum, thereby restoring the skin's natural protective barrier. Additionally, it contains dexpanthenol (panthenol) and glycerin to provide deep hydration and support the skin's natural regeneration processes. Free from emulsifiers, fragrances, preservatives, and parabens, Bepanthenol Sensiderm is highly tolerable and suitable for infants, children, adults, as well as pregnant and breastfeeding women. It has been evaluated in clinical trials, including a Phase 4 exploratory study conducted at Bambino Gesù Children's Hospital comparing its efficacy and tolerability to methylprednisolone aceponate cream in pediatric patients with mild to moderate atopic dermatitis.

Brand names
Bepanthenol SensidermBepanthen SensidermBepanthol Sensicalm
Other names
Bepanthenol Sensiderm Crema

Beyond the preview

Go deeper on Bepanthenol Sensiderm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bepanthenol Sensiderm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call